The role of matrix metalloproteinases and their tissue inhibitors in angiogenesis;Rola metaloproteaz macierzy i ich tkankowych inhibitorów w angiogenezie

Polski Merkuriusz Lekarski

Volumn 21, Issue 121, 2006, Pages 80-85

  Bogaczewicz, Jarosław ^a,c   Dudek, Wojciech ^b,c   Zubilewicz, Tomasz ^b,c   Wroński, Jacek ^b,c   Przywara, Stanisław ^b,c   Chodorowska, Grazyna ^a,c   Krasowska, Dorota ^a,c  

^a Katedra i Klinika Dermatologii   (Poland)

^b Katedra i Klinika Chirurgii Naczy i Angiologii   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Angiogenesis; Matrix metalloproteinases; MMP; TIMP; Tissue inhibitors of metalloproteinases

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CANCER GROWTH FACTOR; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PROTEINASE; VASCULOTROPIN;

ANGIOGENESIS; CELL GROWTH; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; ESTRUS CYCLE; INFLAMMATION; ISCHEMIA; MEDICAL RESEARCH; PREGNANCY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; WOUND HEALING;

ANIMALS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 33747098939     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Bloomston M., Shafii A., Zervos E.E. i wsp.: TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis. J. Surg. Res., 2002, 102, 1, 39-44.
2. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w układzie odpomościowym skóry. Przegl. Dermatol., 2005, 92, 2, 139-149.
3. Bogaczewicz J., Dudek W., Wroński J. i wsp.: Rola metaloproteaz macierzy w powstawaniu owrzodzeń żylnych goleni. Pol. Merk. Lek., 2005, 19, 113, 686-692.
4. Chase A.J., Newby A.C.: Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodelling. J. Vasc. Res., 2003, 40, 4, 329-343.
5. Ferrara N.: Molecular and biological properties of vascular endothelial growth factor. J Mol Med., 199, 77(7), 527-543.
6. Ferreras M., Felbor U., Lenhard T. i wsp.: Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett., 2000, 486, 3, 247-251.
7. Fisher C., Gilbertson-Beadling S., Powers E.A. i iwsp.: Interstitial collagenase is required for angiogenesis in vitro. Dev. Biol. 1994, 162, 2, 499-510.
8. Haas T.L., Davis S.J., Madri J.A.: Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem., 1998, 273, 6, 3604-3610.
9. Hamano Y., Zeisberg M., Sugimoto H. i wsp.: Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer. Cell., 2003, 3, 6, 589-601.
10. Hanemaaijer R., Koolwijk P., le Clercq L. i wsp.: Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem. J., 1993, 296, 3, 803-809.
11. Hashimoto G., Inoki I., Fujii Y. i wsp.: Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J. Biol. Chem., 2002, 277, 39, 36288-36295.
12. Herman M.P., Sukhova G.K., Libby P. i wsp.: Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation, 2001, 104, 16, 1899-1904.
13. Herren B., Levkau B., Raines E.W. i wsp.: Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol. Biol. Cell., 1998, 9, 6, 1589-1601.
14. Hojo Y., Ikeda U., Takahashi M. i wsp.: Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells. J. Mol. Cell. Cardiol., 2000, 32, 8, 1459-1468.
15. Imai K., Hiramatsu A., Fukushima D. i wsp.: Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem. J., 1997, 322, 3, 809-814.
16. Kalluri R.: Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer., 2003, 3, 6, 422-433.
17. Kang J.A., Kim J.T., Song H.S. i wsp.: Anti-angiogenic and anti-tumor invasive activities of tissue inhibitor of metalloproteinase-3 from shark, Scyliorhinus torazame. Biochim. Biophys. Acta., 2003, 1620, 1-3, 59-64.
18. Kim I., Kim H.G., Moon S.O. i wsp.: Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ. Res., 2000, 86, 9, 952-959.
19. Koike T., Vernon R.B., Hamner M.A. i wsp.: MT1-MMP, but not secreted MMPs, influences the migration of human microvascular endothelial cells in 3-dimensional collagen gels. J. Cell. Biochem., 2002, 86, 4, 748-758.
20. Koolwijk P., Sidenius N., Peters E. i wsp.: Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices. Blood., 2001, 97, 10, 3123-3131.
21. Lafleur M.A., Handsley M.M., Knauper V. i wsp.: Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell. Sci., 2002, 115, 17, 3427-3438.
22. Levi E., Fridman R., Miao H.Q. i wsp.: Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc. Natl. Acad. Sci. U S A., 1996, 93, 14, 7069-7074.
23. Li H., Lindenmeyer F., Grenet C. i wsp.: AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. Hum. Gene. Ther., 2001, 12, 5, 515-526.
24. Milkiewicz M., Ispanovic E., Doyle J.L. i wsp.: Regulators of angiogenesis and strategies for their therapeutic manipulation. Int. J. Biochem. Cell Biol., 2006, 38, 3, 333-357.
25. Mohan R., Sivak J., Ashton P. i wsp.: Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J. Biol. Chem., 2000, 275, 14, 10405-10412.
26. Nguyen M., Arkell J., Jackson C.J.: Human endothelial gelatinases and angiogenesis. Int. J. Biochem. Cell. Biol., 2001, 33, 10, 960-970.
27. O'Reilly M.S., Wiederschain D., Stetler-Stevenson W.G. i wsp.: Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J. Biol. Chem., 1999, 274, 41, 29568-29571.
28. Patterson B.C., Sang Q.A.: Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem., 1997, 272, 46, 28823-28825.
29. Qi J.H., Ebrahem Q., Mooreq N. i wsp.: Murphy G, Claesson-Welsh L, Bond M, Baker A, Anand-Apte B. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med., 2003, 9, 4, 407-415.
30. Seo D.W., Li H., Guedez L. i wsp.: TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell., 2003, 114, 2, 171-180.
31. Takigawa M., Nishida Y., Suzuki F. i wsp.: Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun., 1990, 171, 3, 1264-1271.
32. Whitelock J.M., Murdoch A.D. i wsp.: The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem., 1996, 271, 17, 10079-10086.
33. Xu J., Rodriguez D., Petitclerc E. i wsp.: Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J. Cell. Biol., 2001, 154, 5, 1069-1079.
34. Yu Q., Stamenkovic I.: Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes. Dev., 2000, 14, 2, 163-176.
35. Zaragoza C., Balbin M., Lopez-Otin C. i wsp.: Nitric oxide regulates matrix metalloprotease-13 expression and activity in endothelium. Kidney. Int., 2002, 61, 3, 804-808.